QCM
BMRN icon

QRG Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

QRG Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Sell
5,081
-149
-3% -$8.16K ﹤0.01% 1045
2026
Q1 		$295K Buy
+5,230
New +$305K ﹤0.01% 960
2025
Q3 		– Sell
-5,478
Closed -$301K – 1051
2025
Q2 		$301K Buy
+5,478
New +$323K ﹤0.01% 965

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

QRG Capital Management's BMRN Position: Q2 2026 in Review

QRG Capital Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 2.8% in Q2 2026, selling an estimated $8.16K and leaving 5,081 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #1045.

QRG Capital Management first reported a position in BMRN in Q2 2025 and has held it in 3 quarters since. The position peaked at $301K in Q2 2025. 561 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • QRG Capital Management held 5,081 shares of BioMarin Pharmaceuticals worth $291K as of Q2 2026.
  • QRG Capital Management sold 149 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $8.16K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of QRG Capital Management's portfolio in Q2 2026, its #1045 holding.
  • QRG Capital Management first reported a position in BioMarin Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • QRG Capital Management's BioMarin Pharmaceuticals position peaked at $301K in Q2 2025.
  • 561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.